Edition:
United States

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TIAN.SI)

TIAN.SI on Stock Exchange of Singapore

1.08USD
22 Sep 2017
Change (% chg)

$0.00 (+0.47%)
Prev Close
$1.07
Open
$1.07
Day's High
$1.08
Day's Low
$1.07
Volume
156,400
Avg. Vol
874,396
52-wk High
$1.17
52-wk Low
$0.73

Latest Key Developments (Source: Significant Developments)

Tianjin Zhongxin Pharmaceutical Group ‍signed investment product agreement with China Bohai Bank
Thursday, 24 Aug 2017 05:52am EDT 

Aug 24 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>-:Signed investment product agreement with China Bohai Bank to invest rmb200 million into capital-protected investment product​.  Full Article

Tianjin Zhongxin Pharma's chairman and general manager resigns due to change in job role
Thursday, 24 Aug 2017 04:57am EDT 

Aug 24 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:Says Chairman and General Manager Wang Zhiqiang resigns due to change in job role.  Full Article

Tianjin Zhongxin Pharmaceutical Group adopts new accounting policy
Monday, 14 Aug 2017 10:38pm EDT 

Aug 15 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:* Says it adopted new accounting policy disclosed by the Ministry of Finance on May 10, regarding subsidy .* Effective June 12.  Full Article

Tianjin Zhongxin Pharmaceutical says qtrly revenue rmb1.51 billion
Monday, 14 Aug 2017 05:10am EDT 

Aug 14 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>::Qtrly revenue rmb1.51 billion versus rmb 1.62 billion.Qtrly profit net of tax attributable to owners of parent rmb142.1 million versus rmb140.6 million.  Full Article

Tianjin Zhongxin Pharma's H1 net profit up 7.3 pct y/y
Monday, 14 Aug 2017 04:49am EDT 

Aug 14 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:Says H1 net profit up 7.3 percent y/y at 277.5 million yuan ($41.61 million).  Full Article

Tianjin Zhongxin Pharmaceutical Group to pay A shares annual div for FY 2016 on July 14
Thursday, 6 Jul 2017 11:13pm EDT 

July 7 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS> ::* Says it will pay cash dividend of 0.15 yuan(before tax)/share for 2016 to shareholders of record on July 13 .* The company's shares will be traded ex-right and ex-dividend on July 14 and the dividend will be paid on July 14 .  Full Article

Tianjin Zhongxin Pharmaceutical group entered into a share transfer agreement with Jiaxing Yun Shi Tai Yu Investment Partnership​
Tuesday, 27 Jun 2017 05:09am EDT 

June 27 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>-:Entered into a share transfer agreement with Jiaxing Yun Shi Tai Yu Investment Partnership​.‍Company has agreed to sell its entire 20% equity stake in Tianjin Sinobioway Biomedicine Co​.Proposed disposal not expected to have material impact on co's earnings per share for current fy.‍Deal for a cash consideration of rmb47.8 million.  Full Article

Tianjin Zhongxin Pharmaceutical to pay annual cash div as 1.5 yuan per 10 shares for FY 2016
Monday, 3 Apr 2017 01:45am EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS> :Says it plans to pay annual cash dividend as 1.5 yuan(pre-tax) per 10 shares as FY 2016 div payment.  Full Article

Tianjin Zhongxin Pharmaceutical to use up to 6.5 mln yuan to buy 20 pct stake in Chinese medicine unit
Friday, 31 Mar 2017 07:00am EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS> : Says it will use up to 6.5 million yuan to buy 20 percent stake in its Chinese medicine controlling unit, which is in charge of Bozhou industrial park construction project .It will hold 71 percent stake in the Chinese medicine unit after transaction.  Full Article

Tianjin Zhongxin Pharmaceutical signs deal with China Bohai Bank to invest RMB200 mln
Tuesday, 7 Mar 2017 04:20am EST 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS> :Signed an investment product agreement with China Bohai Bank Co Tianjin Branch, to invest a sum of RMB200 million.  Full Article